4 Studies Show Blood Tests May Detect Dementia Up to 25 Years Early
Updated
Updated · Medical News Today · Jul 4
4 Studies Show Blood Tests May Detect Dementia Up to 25 Years Early
3 articles · Updated · Medical News Today · Jul 4
Summary
Four recent studies suggest blood tests could flag dementia risk years before symptoms, including one study linking elevated pTau217 in older women to decline or dementia as far as 25 years later.
Three studies centered on dementia-related proteins—especially pTau217, tau and beta-amyloid—while a fourth used gut microbiome-derived blood metabolites to identify very early cognitive changes.
1,300 CARDIA participants showed one key signal: about 6% with high tau and beta-amyloid had greater cognitive decline five years later; another 317-adult study tied higher baseline pTau217 to faster decline over roughly eight years.
2 FDA-approved pTau217 blood tests are already in clinical use, researchers said, raising hopes for less invasive screening than brain scans or spinal fluid tests.
Small samples and narrow cohorts still limit the evidence, with experts cautioning that findings from 2,766 older women or just 15 adults need broader validation across sexes, ages and racial groups.
Blood tests can now predict dementia years early. Is knowing a future you can't prevent a blessing or a curse?
Could the future of Alzheimer's detection lie not in our brains, but in a simple analysis of our gut health?
Blood-Based p-tau217 Testing for Early Dementia Risk: Transforming Diagnosis, Equity, and Clinical Practice in 2026 and Beyond
Overview
In 2026, major progress was made in early dementia detection with the development of blood-based tests, especially those measuring the biomarker p-tau217. These non-invasive tests have shown high accuracy in identifying Alzheimer’s disease risk, even in older adults who are still cognitively healthy. Research found that higher levels of p-tau217 in the blood strongly increase the likelihood of developing dementia later in life. As p-tau217 levels rise, so does the risk, making these tests a valuable tool for early intervention and planning. This breakthrough marks a new era in dementia diagnosis and care.